CVM.V - CVR Medical Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.2400
0.0000 (0.00%)
As of 12:19PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.2400
Open0.2450
Bid0.23 x 0
Ask0.25 x 0
Day's Range0.2400 - 0.2450
52 Week Range0.2200 - 0.5000
Volume33,732
Avg. Volume81,841
Market Cap27.511M
Beta (3Y Monthly)2.09
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile2 days ago

    CVR Medical Mourns The Passing of Ron Birch, Director

    Denver, North Carolina--(Newsfile Corp. - January 14, 2019) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that Ron Birch, Director passed away January 9th, 2019. Mr. Birch has been a member of the Board of Directors since the inception of CVR Medical in 2016. Peter Bakema, Chairman and CEO commented "It is with heartfelt sadness ...

  • Newsfile9 days ago

    Prestigious Mayo Clinic Approves CVR Medical's CSS Device For IRB Clinical Trial Company Begins Pre-Market Activities With Clinical Foot Print Expansion

    Denver, North Carolina--(Newsfile Corp. - January 7, 2019) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces Internal Review Board (IRB) approval by Mayo Clinic's Gonda Vascular Center sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The famed academic medical center located in Rochester, Minnesota will become the latest distinguished source for ...

  • Newsfile9 days ago

    CVR Medical Completes FDA Submission for Highly Anticipated CSS Device

    Denver, North Carolina--(Newsfile Corp. - January 7, 2019) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces it has completed a Food and Drug Administration De Novo Submission for their "Carotid Stenotic Scan (CSS)" device. A De Novo Submission allows for a company to receive a "not substantially equivalent" risk-based evaluation for any legally marketed device for ...

  • Newsfile20 days ago

    CVR Medical Completes TUV Safety Testing

    Denver, North Carolina--(Newsfile Corp. - December 27, 2018) -  CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces in follow-up to the previously released press release on December 13th, that its patented Carotid Stenotic Scan (CSS) has passed the IEC 60601-1, General Requirements for Basic Safety and Essential Performance - Electrical Safety testing conducted by TUV Rheinland of North America. ...

  • Newsfilelast month

    CVR Medical Provides TUV Safety Testing Update

    Denver, North Carolina--(Newsfile Corp. - December 13, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector announces that its patented, disruptive Carotid Stenotic Scan (CSS) has passed the IEC 60601-1-2 edition 4, General Requirements for Basic Safety and Essential Performance - Electromagnetic Disturbances conducted by TUV Rheinland of North America. TUV Rheinland of North America, is one ...

  • Newsfilelast month

    CVR Medical Announces Financing

    Denver, North Carolina--(Newsfile Corp. - December 5, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical" or the "Company") a Canadian listed and US based healthcare company in the medical device sector announces that it has entered into an agreement with Echelon Wealth Partners Inc. and Leede Jones Gable Inc. (the "Agents") for the sale, on a commercially reasonable efforts private placement basis, up to 28,000,000 units of the Company ...

  • Newsfile2 months ago

    CVR Medical Announces Closing Of Restructuring Transaction with CVR Global, Inc.

    Vancouver, British Columbia--(Newsfile Corp. - November 27, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or the "Company") is pleased to announce that following receipt of final approval from the TSX Venture Exchange, the Company is completing the restructuring transaction (the "Restructuring") with CVR Global, Inc. ("CVR Global"), first announced on May 29, 2018. Pursuant to the Restructuring, CVR Medical is acquiring CVR Global's 50% interest in the companies' ...

  • Newsfile2 months ago

    CVR Medical Provides Update

    Denver, North Carolina--(Newsfile Corp. - November 9, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces submission of the Carotid Stenotic Scan (CSS) to TUV Rheinland for electrical safety and EMC testing. TUV Rheinland is one of the leading providers of product safety certifications worldwide, covering an assortment of items such as medical devices, home ...

  • Newsfile3 months ago

    Leading Medical Device / Life Science / Healthcare Veteran Joel Kanter Joins Board of Directors of CVR Medical

    Denver, North Carolina--(Newsfile Corp. - October 15, 2018) - CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that Mr. Joel Kanter has joined the Board of Directors. Mr. Kanter has served as President of Windy City, Inc. a privately held investment firm since July 1986. Mr. Kanter, is a veteran healthcare venture capitalist whose family office ...

  • Newsfile4 months ago

    CVR Medical Shareholders Approve Restructure

    The Approved Restructuring Provides Clarity, Responsibility and Accountability While Paving the Way to Long-term Success Vancouver, British Columbia--(Newsfile Corp. - September 28, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that on September 26, 2018 the Board of Directors for CVR Medical Corp. (CVM) held a Special Meeting of the Shareholders to approve amongst many things the Restructuring of the Agreement between CVR Medical Corp. and CVR Global ...

  • Newsfile5 months ago

    CVR Medical Announces Proposed Financing

    Vancouver, British Columbia--(Newsfile Corp. - August 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that it intends to complete a non-brokered private placement financing (the "Financing") of units (each, a "Unit") for gross proceeds of up to C$2,000,000 with a price per Unit of C$0.30 or such other price determined by CVR Medical management ...

  • CVR Medical Reports Positive Interim Results from Ongoing Pivotal Trial with CSS Device
    Newsfile5 months ago

    CVR Medical Reports Positive Interim Results from Ongoing Pivotal Trial with CSS Device

    Preliminary Analysis Demonstrates CSS Device Has To Date Exceeded Expectations for Specificity and Sensitivity Compared to Duplex Doppler Ultrasound Vancouver, British Columbia--(Newsfile Corp. - August 21, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip J. Bendick, PhD, has released an internal report summarizing data from the pivotal clinical trials for the Carotid Stenotic ...

  • CVR Medical Enlists JD Lymon Group to Provide Reimbursement and Study Design Support
    Newsfile5 months ago

    CVR Medical Enlists JD Lymon Group to Provide Reimbursement and Study Design Support

    Vancouver, British Columbia--(Newsfile Corp. - August 14, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of Minneapolis-based medical device consulting firm, JD Lymon Group (www.jdlymon.com), to provide ongoing reimbursement guidance and to help support the company's FDA submission of the Carotid Stenotic Scan (CSS) device for US market clearance by ...

  • Newsfile5 months ago

    CVR Medical Retains Global IR/PR Firm ICR To Support Financing and Commercialization Efforts For Its Carotid Stenotic Scan (CSS)

    Vancouver, British Columbia--(Newsfile Corp. - August 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of NYC based Investor Relations Public Relations Firm ICR (www.icrinc.com) to support the company's communications and marketing activities as it explores a US National Market listing and advances toward regulatory submission for its Carotid Stenotic Scan ...

  • CVR Medical Retains Investment Banking Firm ThinkEquity, A Division of Fordham Financial Management, Inc.
    Newsfile7 months ago

    CVR Medical Retains Investment Banking Firm ThinkEquity, A Division of Fordham Financial Management, Inc.

    Company To Explore US Capital Markets Up-Listing Vancouver, British Columbia--(Newsfile Corp. - June 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has exclusively retained ThinkEquity, a division of Fordham Financial Management, Inc., a NYC based, investment banking firm to explore listing onto a major exchange in the United States.CVR CSS DeviceTo view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/1933/35088_cvr6june2018nr.jpgAbout CVR MedicalCVR Medical is a company involved ...

  • Newsfile8 months ago

    CVR Medical And CVR Global Reach Strategic Agreement

    Accord Lays Pathway for Long Term Success Vancouver, British Columbia--(Newsfile Corp. - May 29, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has reached agreement with joint venture partner CVR Global to acquire CVR Global's 50% interest in the joint venture and terminate the joint venture (the "Transaction"). The Agreement has been approved by the Board of Directors for both organizations and is now subject to the approval ...

  • Newsfile8 months ago

    CVR Medical Retains BUYINS.NET to Surveil Short Sellers and Market Makers

    Vancouver, British Columbia--(Newsfile Corp. - May 22, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on CVR Medical (OTCQB: CRRVF) (TSXV: CVM) (FSE: B3BN) after releasing the latest short sale data through May 17, 2018. The total aggregate number of shares shorted ...

  • CVR Medical Adds Colonel Dallas Hack MD, MPH, MSS, FACMPH, FS, CPE To Board of Directors
    Newsfile8 months ago

    CVR Medical Adds Colonel Dallas Hack MD, MPH, MSS, FACMPH, FS, CPE To Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - May 10, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Colonel Dallas C. Hack, MD, MPH, MSS, FACMPH, FS, CPE has been unanimously appointed to its Board of Directors, replacing Mr. Erwin Wong who is retiring. Colonel Hack is a brain injury expert and is board certified in Preventive Medicine with multiple degrees and certifications including a Master of Public Health and a ...

  • CVR & U.S. FDA: A Meeting of the Minds
    Newsfile8 months ago

    CVR & U.S. FDA: A Meeting of the Minds

    Concludes De Novo Pathway Best Suited Vancouver, British Columbia--(Newsfile Corp. - May 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the receipt of official meeting minutes for their Pre-Submission meeting on March 23, 2018 with the U.S. Food and Drug Administration (FDA) regarding the Carotid Stenotic Scan (CSS) device and it's upcoming FDA submission for market release. Attendees of the meeting included CVR management, regulatory consultant's Duval & ...

  • Canon Showcasing Carotid Stenotic Scan (CSS) at NPE the World's Leading Plastic Tradeshow
    Newsfile8 months ago

    Canon Showcasing Carotid Stenotic Scan (CSS) at NPE the World's Leading Plastic Tradeshow

    Vancouver, British Columbia--(Newsfile Corp. - May 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") is pleased to announce that Canon Virginia, Inc. (CVI) will be showcasing our Carotid Stenotic Scan (CSS) at NPE 2018: The Plastics Show, the world's leading plastic tradeshow. Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., provides custom manufacturing solutions, including mold making, injection molding, medical contract manufacturing and automated ...

  • Newsfile8 months ago

    CORRECTION: Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues ...

  • Newsfile8 months ago

    Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues ...

  • Newsfile9 months ago

    CVR Medical Bolsters Board Appoints Wayne Hellman Vice-Chairman

    Global Thought Leader and Entrepreneur Adds Tremendous Expertise in New Product Launches, International Expansion and Manufacturing Vancouver, British Columbia--(Newsfile Corp. - May 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice Chairman. Mr. Hellman will assume an active role focused on the continued development and upcoming launch of CVR Medical's ...

  • Newsfile10 months ago

    CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST (10:00 a.m. PST) is a 7-digit number only. The complete and corrected release follows.Vancouver, British Columbia--(Newsfile Corp. - March ...

  • Newsfile10 months ago

    CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call Vancouver, British Columbia--(Newsfile Corp. - March 16, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 (the "Amended Exercise Price") for the period commencing on March 16, 2018 and ending ...